Comparison of chemiluminescence enzyme immunoassay (CLEIA) with ELISA for the determination of anti-cyclic citrullinated peptide antibodies

Clinica Chimica Acta

Volumn 411, Issue 1-2, 2010, Pages 22-25

  Tanaka, Ryo ^a   Takemura, Masao ^a   Sato, Masao ^a   Yamada, Yasunori ^a   Nakagawa, Takahito ^a   Horibe, Takuro ^b   Hoshi, Masato ^a   Otaki, Hirofumi ^a   Ito, Hiroyasu ^a   Seishima, Mitsuru ^a   Shimizu, Katsuji ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Medical & Biological Laboratories Co Ltd   (Japan)

Author keywords

Analytical performance; Chemiluminescence enzyme immunoassay (CLEIA); Cyclic citrullinated peptide (CCP); Rheumatoid arthritis (RA)

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CHEMILUMINESCENCE ENZYME IMMUNOASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

ANTIBODIES; ARTHRITIS, RHEUMATOID; CITRULLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOENZYME TECHNIQUES; LUMINESCENCE; PEPTIDES, CYCLIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 70449536401     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.09.032     Document Type: Article

References (8)

1. Visser H., Gelinck L.B., Kampfraath A.H., Breedveld F.C., and Hazes J.M. Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis. Ann Rheum Dis 55 (1996) 157-161
2. Avouac J., Gossec L., and Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65 (2006) 845-851
3. Schellekens G.A., Visser H., de Jong B.A., van den Hoogen F.H., Hazes J.M., Breedveld F.C., and van Venrooij W.J. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43 (2000) 155-163
4. Lawrence R.C., Helmick C.G., Arnett F.C., Deyo R.A., Felson D.T., Giannini E.H., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41 (1998) 778-799
5. Boers M., Verhoeven A.C., Markusse H.M., van de Laar M.A., Westhovens R., van Denderen J.C., et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350 (1997) 309-318
6. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
7. Schellekens G.A., de Jong B.A., van den Hoogen F.H., van de Putte L.B., and van Venrooij W.J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101 (1998) 273-281
8. Suzuki K., Sawada T., Murakami A., Matsui T., Tohma S., Nakazono K., et al. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 32 (2003) 197-204